Back
ESC Premium Access

State of the Art - Metabolic aspects of vascular disease

Session: Novel pharmacological targets in vascular disease
Topic: Basic Science
Speaker: Professor M. Federici (Rome, IT)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Massimo Federici

University of Rome Tor Vergata, Rome (Italy)
3 presentations
3 followers

4 more presentations in this session

Role of the gut microbiome for the cholesterol lowering effect of atorvastatin

Speaker: Miss F. Zimmermann (Berlin, DE)

Access
Abstract
Slides
Video
Thumbnail

Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension -high-throughput screening of 5,562 compounds-

Speaker: Doctor R. Kurosawa (Sendai, JP)

Access
Abstract
Slides
Video
Thumbnail

The SGLT2 inhibitor empagliflozin reduces mortality in experimental pulmonary hypertension

Speaker: Professor S. Verma (Toronto, CA)

Access
Abstract
Slides
Video
Thumbnail

Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury

Speaker: Professor R. Touyz (Montreal, CA)

Access
Slides
Video
Thumbnail

Access the full session

Novel pharmacological targets in vascular disease

Speakers: Professor M. Federici, Miss F. Zimmermann, Doctor R. Kurosawa, Professor S. Verma, Professor R. Touyz
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb